Nocturnal enuresis.

Area of Science:

• Pediatrics
• Urology
• Genetics

Background:

• Nocturnal enuresis is a prevalent childhood condition with significant familial and emotional impact.
• Emerging research suggests nocturnal enuresis is a complex condition with multifactorial etiologies, potentially involving genetic predispositions.
• Two primary patient subtypes are identified: those with functional bladder disorders and those with delayed nocturnal arginine vasopressin (AVP) secretion.

Purpose of the Study:

• To review the current understanding of nocturnal enuresis, including its diverse causes and classification.
• To outline the diagnostic approach for children experiencing nocturnal enuresis.
• To summarize available treatment strategies and their respective efficacy and relapse rates.

Main Methods:

• Comprehensive review of recent scientific literature on nocturnal enuresis.
• Analysis of diagnostic criteria including patient history, physical examination, and urinalysis.
• Evaluation of non-pharmacologic (e.g., alarms, continence training) and pharmacologic (e.g., desmopressin, imipramine) treatment options.

Main Results:

• Nocturnal enuresis is increasingly viewed as a heterogeneous condition with potential genetic links.
• Diagnostic evaluation involves a thorough clinical assessment and laboratory tests.
• Bed-wetting alarms demonstrate the highest cure rates and lowest relapse rates, though adherence can be challenging. Medications like desmopressin and imipramine have high relapse rates.

Conclusions:

• Nocturnal enuresis requires a personalized treatment approach based on identified subtypes and patient factors.
• Bed-wetting alarms are a highly effective first-line treatment for nocturnal enuresis.
• Further research into the genetic and maturational aspects of nocturnal enuresis is warranted to refine treatment strategies.